Literature DB >> 113694

Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patients.

J H Wood, T A Hare, B S Glaeser, J C Ballenger, R M Post.   

Abstract

Gamma-Aminobutyric acid (GABA) has been implicated in the neurochemistry of epilepsy. Lumbar cerebrospinal fluid (CSF) GABA concentrations determined using an ion-exchange fluorometric assay reflect brain GABA content. The mean lumbar CSF GABA concentration among 21 medicated patients with intractable seizures was significantly lower (p less than 0.001) than that of 20 unmedicated normal volunteers. Patients with generalized tonic-clonic (grand mal) and complex partial (psychomotor) seizures had significantly lower (p less than 0.05) CSF GABA concentrations than those with simple partial (focal sensory/motor) seizures. Although lumbar CSF GABA levels in our seizure patients did not significantly correlate with serum concentrations of phenytoin, phenobarbital, or primidone, additional study of medication-free epileptic patients may be required to evaluate the possibility of anticonvulsant-drug-induced CSF GABA alterations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 113694     DOI: 10.1212/wnl.29.9_part_1.1203

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.

Authors:  A T Zepeda; F J Ortiz Nesme; J Méndez-Franco; E Otero-Siliceo; M Pérez de la Mora
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

Review 2.  Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.

Authors:  O A Petroff; D L Rothman
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

3.  Modulatory effects of activation of metabotropic glutamate receptors on GABAergic circuits in the mouse cortex.

Authors:  Tingting Liu; Iraklis Petrof; S Murray Sherman
Journal:  J Neurophysiol       Date:  2014-03-12       Impact factor: 2.714

Review 4.  Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.

Authors:  T A Hare
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

Review 5.  GABAergic mechanisms in the pathogenesis and treatment of epilepsy.

Authors:  B S Meldrum
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

6.  Prolactin levels in febrile and afebrile seizures.

Authors:  P Sifianou; C Mengreli; G Makaronis; S Pantelakis
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

7.  Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.

Authors:  D Schmidt; W Löscher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

8.  Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis.

Authors:  D Rating; H Siemes; W Löscher
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

9.  Plasma and cerebrospinal fluid amino acids in epileptic patients.

Authors:  Sirpa Rainesalo; Tapani Keränen; Johanna Palmio; Jukka Peltola; Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

10.  Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Halonen; R Kutvonen; P Hartikainen; P Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.